Prevest Denpro
393.20
-14.80(-3.63%)
Market Cap₹471.94 Cr
PE Ratio24.73
IndustryHealthcare
Company Performance:
1D-3.63%
1M-9.30%
6M-11.73%
1Y-21.54%
5Y+107.44%
View Company Insightsright
More news about Prevest Denpro
27Apr 26
Prevest Denpro Limited Announces Director Cessation Upon Completion of Tenure
Prevest Denpro Limited announced that Mr. Pardeep Gandotra (DIN: 08733719) ceased as Independent Director on April 26, 2026, upon completion of his tenure. The company filed the required regulatory disclosure under SEBI Listing Regulations on April 27, 2026, with Managing Director Atul Modi signing the notification.
 no imag found
09Apr 26
Prevest Denpro Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026
Prevest Denpro Limited filed its quarterly SEBI compliance certificate with BSE on April 08, 2026, for the quarter ended March 31, 2026. The certificate confirms that Regulation 74(5) is not applicable as all company shares remain in dematerialised form, with no rematerialisation requests received during the quarter. The filing was supported by documentation from registrar Bigshare Services Pvt. Ltd, demonstrating continued regulatory compliance.
 no imag found
07Apr 26
Prevest Denpro Limited Announces Resignation of Company Secretary and Compliance Officer
Prevest Denpro Limited has announced the resignation of Company Secretary and Compliance Officer Mr. Aman Sadhotra, effective April 6, 2026. The resignation was submitted to pursue personal growth and professional development opportunities. The company has complied with all SEBI regulatory requirements and provided necessary disclosures to the stock exchanges.
 no imag found
14Feb 26
Prevest DenPro Board Approves Q3FY26 Financial Results for Quarter Ended December 31
Prevest DenPro Limited successfully concluded its board meeting on February 14, 2026, approving unaudited standalone and consolidated financial results for Q3FY26 quarter ended December 31, 2025. The meeting addressed regulatory compliance under SEBI regulations, with statutory auditors Mittal & Associates providing limited review reports for the consolidated structure including subsidiaries.
 no imag found
24Nov 25
Prevest DenPro Reports Strong H1 FY26 Growth, Sets Ambitious Revenue Target
Prevest Denpro Limited reported impressive financial results for H1 FY26. Revenue increased by 16.14% to Rs 34.41 crore, with a maintained EBITDA margin of 39.04%. Export revenue grew by 24%. The company's growth is driven by digital dentistry solutions, 3D printing products, and US market expansion through its subsidiary Axiodent. Prevest Denpro aims to cross Rs 100 crore in revenue within the next three years.
 no imag found
12Nov 25
Prevest Denpro Reports 17% Growth in Net Profit and Revenue for Q2 FY2026
Prevest Denpro Limited, a dental materials manufacturer, announced Q2 FY2026 results with net profit rising 16.67% to ₹56.00 crore and revenue increasing 14.72% to ₹187.00 crore year-over-year. The Board of Directors approved these results on November 12, 2025. Auditors Mittal & Associates found no issues with the financial statements.
 no imag found
15Aug 25
Prevest Denpro Limited Announces 26th Annual General Meeting on September 10, 2025
Prevest Denpro Limited, a dental materials manufacturer, will hold its 26th Annual General Meeting (AGM) on September 10, 2025, at 12:30 PM IST via video conferencing. The virtual AGM, hosted on the National Securities Depository Limited (NSDL) platform, complies with regulatory guidelines allowing remote meetings until September 30, 2025. Shareholders can access meeting details and participate through the VC/OAVM facility, with attendance counted for quorum. The AGM Notice will be sent electronically to registered email addresses, and unregistered shareholders are urged to provide their email information.
 no imag found
07Aug 25
Prevest DenPro to Consider Q1 Results and BSE Main Board Migration in Upcoming Board Meeting
Prevest Denpro Limited, currently listed on BSE's SME Platform, has scheduled a Board of Directors meeting for August 13, 2025. The agenda includes approving Q1 FY2025-26 financial results, recommending a final dividend for FY2024-25, finalizing details for the 26th AGM via video conferencing, and considering a proposal to migrate from BSE's SME Platform to the Main Board. This potential migration could significantly increase the company's visibility and attract a broader investor base.
 no imag found
09Jun 25
Prevest Denpro Inks Strategic MoU with Indian Dental Association
Prevest Denpro, a leading dental materials and equipment company, has signed a Memorandum of Understanding (MoU) with the Indian Dental Association (IDA). The partnership aims to advance dental research and improve public health in India. The collaboration focuses on fostering innovation in dental science, developing new dental products, enhancing professional development for dental practitioners, and raising public awareness about oral hygiene. This strategic alliance is expected to have a significant impact on the dental industry in India, potentially leading to improved dental health standards across the country.
 no imag found
06Jun 25
PrevEST Denpro Inks Strategic MOU with Indian Dental Association
PrevEST Denpro has entered into a strategic Memorandum of Understanding (MOU) with the Indian Dental Association (IDA) to enhance dental research and improve public health initiatives in India's dental sector. The collaboration aims to facilitate comprehensive research, implement effective awareness campaigns, and advance dental care standards and practices. This partnership is expected to have significant implications for dental health outcomes, professional development for dentists, and innovation in dental products and techniques.
 no imag found
Prevest Denpro
393.20
-14.80
(-3.63%)
1 Year Returns:-21.54%
Industry Peers
Poly Medicure
1,349.70
(+1.46%)
Laxmi Dental
232.55
(-4.35%)
Tarsons Products
209.46
(-2.57%)
Osel Devices
492.85
(-0.78%)
Vasa Denticity
434.55
(+7.07%)
Fabtech Technologies
155.38
(-2.26%)
Prevest Denpro
393.20
(-3.63%)
Aprameya Engineering
156.10
(-9.77%)
Nureca
281.45
(+3.42%)